About
MISO Chip develops a microfluidic platform that enables ex vivo testing of anticancer agents on patient-derived tumor explants, preserving the native tumor microenvironment to improve preclinical drug development and translational oncology studies.
Explore MISO Chip's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.